Related references
Note: Only part of the references are listed.Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
Sun Joo Lee et al.
CLINICAL CANCER RESEARCH (2012)
The role of ATP-binding cassette transporters in bacterial pathogenicity
Victoria G. Lewis et al.
PROTOPLASMA (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides
Miranda P. Ween et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
S. Shukla et al.
CURRENT DRUG TARGETS (2011)
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells
Miranda P. Ween et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
Miranda P. Ween et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma
Z. Qin et al.
LEUKEMIA (2011)
Reduction of Hyaluronan-CD44-Mediated Growth, Migration, and Cisplatin Resistance in Head and Neck Cancer Due to Inhibition of Rho Kinase and PI-3 Kinase Signaling
Carlos Torre et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2010)
Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
Giovanni Luca Beretta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
ABC transporter gene expression in benign and malignant ovarian tissue
Veronika Auner et al.
GYNECOLOGIC ONCOLOGY (2010)
Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-κB (NF-κB) Pathway
Davide Vigetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene
Jia-jia Ma et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2009)
Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
H. Chen et al.
BRITISH JOURNAL OF CANCER (2009)
Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides
Mark G. Slomiany et al.
CANCER RESEARCH (2009)
Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling
Chi-Mou Liu et al.
CELL AND TISSUE RESEARCH (2009)
Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis
Areeg Faggad et al.
HISTOPATHOLOGY (2009)
Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors
Anne G. Gilg et al.
CLINICAL CANCER RESEARCH (2008)
A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent In vivo therapeutic activity
Alessandra Banzato et al.
CLINICAL CANCER RESEARCH (2008)
Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Bryan P. Toole et al.
DRUG RESISTANCE UPDATES (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer
Duygu Derin et al.
LUNG CANCER (2008)
Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
Lilly Y. W. Bourguignon
SEMINARS IN CANCER BIOLOGY (2008)
Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway
Rosalia I. Cordo Russo et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs
Richard M. Logan et al.
CANCER TREATMENT REVIEWS (2007)
Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell
Rina Ohashi et al.
CANCER LETTERS (2007)
Hyaluronic acid-paclitaxel: Antitumor efficacy against CD44(+) human ovarian carcinoma xenografts
Edmond Auzenne et al.
NEOPLASIA (2007)
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome
Pawel Surowiak et al.
CLINICAL CANCER RESEARCH (2006)
RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells
Verena Materna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer
Steven J. Wang et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas
E Yakirevich et al.
GYNECOLOGIC ONCOLOGY (2006)
The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer
KE Miletti-González et al.
CANCER RESEARCH (2005)
Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2
S Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
S Suwiwat et al.
CLINICAL CANCER RESEARCH (2004)
Hyaluronan: From extracellular glue to pericellular cue
BP Toole
NATURE REVIEWS CANCER (2004)
Regulation of multidrug resistance in cancer cells by hyaluronan
S Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma
T Vincent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Expression of hyaluronate and hyaluronate synthase in human primary tumours an their metastases in scid mice
M Jojovic et al.
CANCER LETTERS (2002)
Multidrug resistance gene-1 is a useful predictor of paclitaxel-based chemotherapy for patients with ovarian cancer
S Kamazawa et al.
GYNECOLOGIC ONCOLOGY (2002)
Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays
GE Sandusky et al.
HISTOPATHOLOGY (2002)
Complete characterization of the human ABC gene family
M Dean et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2001)
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
P Auvinen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
CD44 and beta 1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins
RC Casey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
Share Paper
